72 participants
A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-11-03
Conditions
- HIV Infections
Interventions
- BIOLOGICAL
No Results Yet